Table 2 Office and ambulatory blood pressure measurements at the end of intervention
Blood Pressure | Propranolol (mmHg) | Placebo (mmHg) | P value |
|---|---|---|---|
Office Blood pressure at end of intervention | |||
SBP (Systolic BP) | 130.0 ± 13.2 | 139.93 ± 14.17 | 0.046 |
DBP (Diastolic BP) | 77.8 (± 9.7) | 82.66 ± 8.58 | 0.142 |
Mean reduction in office SBP | 29.7 ± 13.0 | 18.07 ± 14.63 | 0.021 |
Mean reduction in office DBP | 12.4 ± 12.8 | 6.33 ± 16.59 | 0.242 |
Mean ambulatory BP at the end of intervention | |||
SBP (Systolic BP) | 137.3 ± 12.6 | 149.2 ± 12.5 | 0.080 |
DBP (Diastolic BP) | 79.4 ± 5.5 | 84.1 ± 8.4 | 0.050 |
Mean reduction in ambulatory SBP | 11.2 ± 14.7 | 4.1 ± 13.3 | 0.138 |
Mean reduction ambulatory DBP | 5.4 ± 6.1 | − 3.5 ± 15.6 | 0.031 |